Market News
Stay updated with the latest market trends, earnings, and economic indicators.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stock Market LIVE: Sensex up 300 pts, Nifty above 23,850; IT, pharma & healthcare stocks lead
Sensex Today | Stock Market LIVE Updates Wednesday: In the broader markets, the Nifty MidCap and the Nifty SmallCap were trading 0.04 per cent and 0.12 per cent lower, respectively
Tech-Led global selloff, Fed rate fears weigh on Indian equities
Indian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE Sensex both fell significantly, influenced by a strong US dollar and profit-taking after recent gains. While pharma and healthcare sectors showed resilience, most others, including metals and IT, declined. Market volatility increased, with analysts watching key support levels closely.
Worst is behind us, markets could hit new highs in 6-12 months: Envision’s Nilesh Shah
Nilesh Shah, Founder of Envision Capital, remains positive on digital platforms, defence, aerospace and consumer discretionary sectors, citing long-term domestic growth drivers. Shah expects stronger earnings, policy reforms and foreign investor participation to support markets, while also identifying opportunities linked to GLP-1 drugs, nutrition products and healthcare themes.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
Stocks in news: Dr Reddy’s, Adani Green, KIMS, JSW Energy, Nestle India
Markets saw a strong rebound on Friday, driven by positive global cues and easing geopolitical tensions. Nifty defended the 23,000 support and reclaimed 23,500, with potential for further gains. Several stocks like Dr Reddy's, Adani Green, and JSW Energy are in focus due to significant corporate developments.
Bulls Take Charge: GIFT Nifty points to gap-up opening for Dalal Street
Indian equity markets concluded a volatile week on a strong note, breaking a two-week losing streak. This surge was fueled by improving global sentiment and supportive RBI measures. The upcoming week's trading will be influenced by domestic macroeconomic data and key global policy developments, including US-Iran negotiations impacting crude oil prices.
INR surges amid sharp pull back in oil prices; Sensex and Nifty jump by around 2%
The Indian rupee surged 67 paise to close at 95.18 (provisional) against the greenback on Friday as global oil prices fell sharply after US President Donald Trump indicated an imminent deal with Iran. A firm trend in domestic equity markets and a weaker American currency also supported the rupee during the day. Indian shares closed Friday's session on a buoyant note in a broad-based rally, with both frontline and broader market indexes posting sharp gains. The BSE Sensex settled at 75,527.95, surging 1,695.40 points (2.30%), and the NSE Nifty50 ended at 23,622.90, climbing 461.30 points (1.99%). Trump has reportedly said a deal to end the war with Iran is nearly complete, and is expected to be signed over the weekend in Europe, as he called off military strikes on the Islamic Republic hours after threatening to take control of its oil industry.
SpaceX IPO: How To Trade The World's Largest Ever Public Issue In Asia's Locked-Out Markets
Companies linked to SpaceX have particularly attracted bets that a fresh influx of capital
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.